BIOMAT Database Logo BIOMAT Database Logo

Nitric oxide rescues thalidomide mediated teratogenicity. 2012

Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Vascular Biology Lab, AU-KBC Research Centre, Anna University, MIT Campus, Chennai, India.

Thalidomide, a sedative drug given to pregnant women, unfortunately caused limb deformities in thousands of babies. Recently the drug was revived because of its therapeutic potential; however the search is still ongoing for an antidote against thalidomide induced limb deformities. In the current study we found that nitric oxide (NO) rescues thalidomide affected chick (Gallus gallus) and zebrafish (Danio rerio) embryos. This study confirms that NO reduced the number of thalidomide mediated limb deformities by 94% and 80% in chick and zebrafish embryos respectively. NO prevents limb deformities by promoting angiogenesis, reducing oxidative stress and inactivating caspase-3 dependent apoptosis. We conclude that NO secures angiogenesis in the thalidomide treated embryos to protect them from deformities.

UI MeSH Term Description Entries
D008297 Male Males
D009139 Musculoskeletal Abnormalities Congenital structural abnormalities and deformities of the musculoskeletal system. Abnormalities, Musculoskeletal,Abnormality, Musculoskeletal,Musculoskeletal Abnormality
D002374 Catalase An oxidoreductase that catalyzes the conversion of HYDROGEN PEROXIDE to water and oxygen. It is present in many animal cells. A deficiency of this enzyme results in ACATALASIA. Catalase A,Catalase T,Manganese Catalase,Mn Catalase
D002642 Chick Embryo The developmental entity of a fertilized chicken egg (ZYGOTE). The developmental process begins about 24 h before the egg is laid at the BLASTODISC, a small whitish spot on the surface of the EGG YOLK. After 21 days of incubation, the embryo is fully developed before hatching. Embryo, Chick,Chick Embryos,Embryos, Chick
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001011 Aorta The main trunk of the systemic arteries. Aortas
D013096 Spermine A biogenic polyamine formed from spermidine. It is found in a wide variety of organisms and tissues and is an essential growth factor in some bacteria. It is found as a polycation at all pH values. Spermine is associated with nucleic acids, particularly in viruses, and is thought to stabilize the helical structure.
D013723 Teratogens An agent that causes the production of physical defects in the developing embryo. Embryotoxins,Fetotoxins,Teratogen

Related Publications

Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells.
April 2006, BMC cell biology,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Mechanisms of thalidomide teratogenicity.
August 1999, Nature medicine,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Thalidomide inhibits interferon-γ-mediated nitric oxide production in mouse vascular endothelial cells.
January 2011, Cellular immunology,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
[Molecular mechanism of thalidomide teratogenicity].
February 2011, Seikagaku. The Journal of Japanese Biochemical Society,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Target identification: unravelling thalidomide teratogenicity.
May 2010, Nature reviews. Drug discovery,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Thalidomide inhibits lipopolysaccharide-induced nitric oxide production and prevents lipopolysaccharide-mediated lethality in mice.
August 2009, FEMS immunology and medical microbiology,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity.
May 1999, Nature medicine,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Thalidomide, semen distribution, teratogenicity... and cost.
March 2006, The British journal of dermatology,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Deciphering the mystery of thalidomide teratogenicity.
March 2012, Congenital anomalies,
Jamila H Siamwala, and Vimal Veeriah, and M Krishna Priya, and Saranya Rajendran, and Uttara Saran, and Swaraj Sinha, and Shunmugam Nagarajan, and T Pradeep, and Suvro Chatterjee
Low nitric oxide: a key factor underlying copper-deficiency teratogenicity.
December 2007, Free radical biology & medicine,
Copied contents to your clipboard!